Subscribe To
Seeing machines' top line growth beats market forecasts
Seeing Machines Ltd (AIM:SEE, OTC:SEEMF) said revenues for the year increased by a better-than-expected 48% to US$57.8 million as its eye-tracking te...
October 16, 2023, 3:01 am
Buy yang to profit from china's bursting bubble
Chinese stocks are expected to decline significantly due to geopolitical tensions with the USA, a bursting real estate bubble, and global recession ri...
October 16, 2023, 2:58 am
Pfizer's sequel: return of the value stock
Pfizer is focusing on its core growth engines and strategic acquisitions, particularly in the oncology segment, to compensate for downgraded revenue p...
October 16, 2023, 2:53 am
Guild esports player chico wins 3rd place in fortnite champion series
Professional Fortnite player 'Chico' has won $200,000 after finishing third in the prestigious Fortnite Champion Series final while playing under the ...
October 16, 2023, 2:32 am
Denbury: a deep dive into financial metrics, liquidity concerns, and investment potential
Denbury Inc.'s balance sheet shows growth in total assets and stockholders' equity, but also a significant ...
October 16, 2023, 2:31 am
Pboc sets usd/ cny reference rate for today at 7.1798 (vs. estimate at 7.3121)
The People's Bank of China set the onshore yuan (CNY) reference rate for the trading session ahead.USD/CNY is the onshore yuan. Its permitted to trade...
October 16, 2023, 1:15 am
Scalper signal mt4 indicator
In the ever-evolving world of forex trading, having the right tools at your disposal can make all the difference between success and failure. One such...
October 16, 2023, 12:00 am
Netflix: headwinds, just how big?
Netflix's share price has been under pressure due to lagging expectations in cracking down on password sharing and generating advertising revenues. Th...
October 15, 2023, 11:54 pm
Enghouse systems: the transition to saas is promising
Enghouse Systems is a Canadian software and services company that specializes in customer engagement solutions and telecommunications software. EGHSF ...
October 15, 2023, 11:39 pm
Super micro computer: price consolidation amid strong fundamentals
Super Micro Computer, Inc. reported impressive Q4 2023 financial results with a significant increase in...
October 15, 2023, 9:24 pm
Activist builds news corp stake, plans to seek changes
Starboard believes the media company trades at a significant discount due to its structure....
October 15, 2023, 7:00 pm
Transforming the crypto landscape with bitcoin, ethereum, and bitcoin spark’s unmatched vision
Bitcoin and Ethereum birthed the digital currency ecosphere. These two digital assets play a significant ...
October 15, 2023, 1:59 pm
Should you buy bitcoin while it’s below $30,000?
Looking out even 12 months from now, it’s possible that Bitcoin’s price will be significantly higher than today, which means buying it for less th...
October 15, 2023, 10:29 am
A bull market could be here: 3 reasons to buy coca-cola stock
Its ability to innovate and adapt is a significant driver behind its consistent revenue growth. Its upw...
October 15, 2023, 8:15 am
Exxon mobil: is it a good dividend stock?
Exxon Mobil has been a reliable dividend player but that doesn't mean ex-ante the dividend was never at risk. The company's scale and integrated model...
October 15, 2023, 6:25 am
Assertio holdings: uncovering a tapestry of trading opportunities from this oversold ticker
Assertio Holdings has undergone a significant transformation in its business model, reducing debt and e...
October 15, 2023, 4:41 am
Ethereum’s prolonged battle with bitcoin: who’s winning?
The gripping saga between Ethereum and Bitcoin has seen its highs and lows, twists and turns. And as the plot thickens in 2023, Ethereum’s native to...
October 15, 2023, 2:14 am
Rising us bond yields drive fpis to sell indian equities
In a significant financial shift, foreign portfolio investors (FPIs) continue their selling streak in I...
October 15, 2023, 12:59 am
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm